Published in Hepatology on April 25, 2014
Spironolactone Therapy In Young Women With NASH | NCT03576755
Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. PLoS One (2015) 1.68
Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat Commun (2017) 1.39
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. J Lipid Res (2015) 1.07
NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD. Nat Rev Gastroenterol Hepatol (2015) 1.05
Management of NAFLD: a stage-based approach. Nat Rev Gastroenterol Hepatol (2016) 0.97
Hepatocellular carcinoma: a review. J Hepatocell Carcinoma (2016) 0.95
The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol (2016) 0.93
Hepatitis C virus-induced hepatocellular carcinoma. Clin Mol Hepatol (2015) 0.91
Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Mayo Clin Proc (2015) 0.90
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis. Nutrients (2015) 0.87
Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain. J Virol (2014) 0.87
Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study. World J Gastroenterol (2016) 0.84
Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review. Dig Dis Sci (2015) 0.84
Molecular classification of hepatocellular carcinoma: potential therapeutic implications. Hepat Oncol (2015) 0.84
Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases. J Clin Transl Hepatol (2015) 0.83
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Dig Dis Sci (2017) 0.82
Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma. World J Hepatol (2015) 0.82
p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer. FEBS Lett (2016) 0.82
Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation. Dig Dis Sci (2015) 0.82
Current and Future Burden of Chronic Nonmalignant Liver Disease. Clin Gastroenterol Hepatol (2015) 0.81
NAFLD and liver transplantation: Current burden and expected challenges. J Hepatol (2016) 0.81
Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study. World J Gastroenterol (2014) 0.81
Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation. Dig Dis Sci (2016) 0.81
PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis. Oncotarget (2015) 0.80
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma. BMC Cancer (2015) 0.80
Micro RNAs in the development of non-alcoholic fatty liver disease. World J Hepatol (2015) 0.79
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances. F1000Res (2016) 0.78
Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival. Curr Opin Organ Transplant (2016) 0.78
NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed? Visc Med (2016) 0.78
Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol (2014) 0.78
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol (2017) 0.78
Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease. World J Gastroenterol (2014) 0.77
Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. World J Gastroenterol (2016) 0.77
Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. Hepatology (2016) 0.77
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int (2017) 0.77
Increased risk of colorectal polyps in patients with non-alcoholic fatty liver disease undergoing liver transplant evaluation. J Gastrointest Oncol (2015) 0.76
Body Roundness Index and Waist-to-Height Ratio are Strongly Associated With Non-Alcoholic Fatty Liver Disease: A Population-Based Study. Hepat Mon (2016) 0.76
Liver Bid suppression for treatment of fibrosis associated with non-alcoholic steatohepatitis. J Hepatol (2015) 0.76
Hepatocellular Carcinoma is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States. Clin Gastroenterol Hepatol (2016) 0.76
Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma. Oncotarget (2016) 0.75
Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list. World J Hepatol (2016) 0.75
Role of Hedgehog Signaling Pathway in NASH. Int J Mol Sci (2016) 0.75
c-Jun N-terminal kinase-mediated Rubicon expression enhances hepatocyte lipoapoptosis and promotes hepatocyte ballooning. World J Gastroenterol (2016) 0.75
Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice. Lipids Health Dis (2017) 0.75
Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma. Oncotarget (2016) 0.75
Personalized management of hepatocellular carcinoma based on molecular information: future prospects. Clin Liver Dis (Hoboken) (2015) 0.75
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. World J Gastroenterol (2016) 0.75
The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol (2017) 0.75
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World J Hepatol (2017) 0.75
Succinct guide to liver transplantation for medical students. Ann Med Surg (Lond) (2016) 0.75
Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials. Gastroenterol Hepatol (N Y) (2016) 0.75
Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans. Cell Rep (2017) 0.75
Is vitamin e or ursodeoxycholic acid a valid treatment option for nonalcoholic fatty liver disease in 2016? Saudi J Gastroenterol (2016) 0.75
Overexpression of variant PNPLA3 gene at I148M position causes malignant transformation of hepatocytes via IL-6-JAK2/STAT3 pathway in low dose free fatty acid exposure: a laboratory investigation in vitro and in vivo. Am J Transl Res (2016) 0.75
Medical Management of Metabolic Complications of Liver Transplant Recipients. Gastroenterol Hepatol (N Y) (2016) 0.75
Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells. Transl Res (2017) 0.75
The association of nonalcoholic steatohepatitis and obstructive sleep apnea. Eur J Gastroenterol Hepatol (2017) 0.75
Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience. Transplant Direct (2017) 0.75
Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease. Nutrients (2017) 0.75
Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation. Dig Dis Sci (2017) 0.75
NLRP3 Deletion Inhibits the Non-alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid. Inflammation (2017) 0.75
Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States. J Clin Transl Hepatol (2017) 0.75
Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis. Sci Rep (2017) 0.75
Gastrointestinal Complications of Obesity. Gastroenterology (2017) 0.75
Screening Strategies for Nonalcoholic Steatohepatitis in High-Risk Individuals: Trimming Away the Fat. Dig Dis Sci (2016) 0.75
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol (2005) 3.09
Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis (2009) 3.08
Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology (2006) 2.03
Older age and liver transplantation: a review. Liver Transpl (2004) 1.73
Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology (2003) 1.57
Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry. Liver Transpl (2014) 1.56
Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection. Hepatology (2011) 1.49
Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease. Am J Cardiol (2011) 1.46
The epidemiology of hepatitis C virus infection. J Clin Gastroenterol (2003) 1.08
Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection. J Hepatol (2009) 1.02
Ethnic disparities in the association of body mass index with the risk of hypertension and diabetes. J Community Health (2014) 0.99
Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy. Clin Gastroenterol Hepatol (2006) 0.97
Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies. Clin Gastroenterol Hepatol (2012) 0.96
High frequency of recurrent viremia after hepatitis B e antigen seroconversion and consolidation therapy. J Clin Gastroenterol (2012) 0.95
Expression of chemokine receptors on intrahepatic and peripheral lymphocytes in chronic hepatitis C infection: its relationship to liver inflammation. J Infect Dis (2004) 0.93
Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities? Am J Gastroenterol (2009) 0.93
Diabetes mellitus increases the risk of mortality following liver transplantation independent of MELD score. Dig Dis Sci (2010) 0.92
Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review. Dig Dis Sci (2015) 0.91
Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. Cancer Causes Control (2012) 0.91
Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine. J Clin Gastroenterol (2003) 0.88
Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma. Dig Dis Sci (2013) 0.87
Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice. Eur J Gastroenterol Hepatol (2013) 0.87
Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data. Clin Transplant (2014) 0.87
Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice. J Gastroenterol Hepatol (2013) 0.86
Both HCV and HBV are major causes of liver cancer in Southeast Asians. J Immigr Minor Health (2013) 0.85
Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation. Liver Transpl (2014) 0.85
Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders. Dig Dis Sci (2012) 0.85
The asymptomatic outpatient with abnormal liver function tests. Clin Liver Dis (2009) 0.85
Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation. Am J Gastroenterol (2011) 0.84
National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection. J Clin Gastroenterol (2006) 0.83
Endoscopic approach to the treatment of gastrointestinal bleeding. Tech Vasc Interv Radiol (2004) 0.83
Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation. Dig Dis Sci (2015) 0.82
Long term trends and racial/ethnic disparities in the prevalence of obesity. J Community Health (2014) 0.82
Prevalence of colorectal neoplasms in Asian Americans. Dig Dis Sci (2008) 0.82
Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir. Dig Dis Sci (2015) 0.82
Donor diabetes mellitus is an independent risk factor for graft loss in HCV positive but not HCV negative liver transplant recipients. Dig Dis Sci (2012) 0.81
Portal, splenic, and superior mesenteric vein thrombosis in a patient with latent essential thrombocythemia and hyperhomocysteinemia. J Clin Gastroenterol (2006) 0.81
Bidirectionally adjustable TIPS reduction by parallel stent and stent-graft deployment. J Vasc Interv Radiol (2008) 0.81
Real-world outcomes of ledipasvir/sofosbuvir in treatment-naive patients with hepatitis C. Am J Manag Care (2016) 0.81
Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database. Clin Transplant (2014) 0.80
Task-Shifting: An Approach to Decentralized Hepatitis C Treatment in Medically Underserved Areas. Dig Dis Sci (2015) 0.80
Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients. Dig Dis Sci (2013) 0.80
Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature. Dig Dis Sci (2014) 0.80
High rate of complete viral suppression with combination therapy in patients with chronic hepatitis B and prior treatment failure. J Clin Gastroenterol (2011) 0.80
Living donor liver transplantation in a patient with hepatic epithelioid hemangioendothelioma. J Clin Gastroenterol (2003) 0.79
Recurrent hepatocellular carcinoma and poorer overall survival in patients undergoing left-sided compared with right-sided partial hepatectomy. J Clin Gastroenterol (2015) 0.79
Acute Liver Failure: A Potential Complication of Antithyroid Medication Use. Dig Dis Sci (2014) 0.78
Screening for esophageal varices in cirrhotic patients: endoscope, platelet count, or both? Gastrointest Endosc (2006) 0.78
Fatal Accelerated Cirrhosis after Imported HEV Genotype 4 Infection. Emerg Infect Dis (2015) 0.78
Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care. Medicine (Baltimore) (2016) 0.77
Phenotypic and functional status of intrahepatic T cells in chronic hepatitis C. J Infect Dis (2006) 0.76
Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines. J Clin Gastroenterol (2013) 0.76
Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease. Medicine (Baltimore) (2017) 0.75
Trends in Liver Transplantation in Hepatitis C Virus-Infected Persons, United States. Emerg Infect Dis (2016) 0.75
Adenovirus-induced acute liver failure. Dig Dis Sci (2008) 0.75
Treating Medicaid patients with hepatitis C: clinical and economic impact. Am J Manag Care (2017) 0.75
Progressive asymptomatic occlusion of a TIPS in a patient with Budd-Chiari syndrome. J Vasc Interv Radiol (2006) 0.75
Pseudomyxoma peritonei masquerading as ascites secondary to alcoholic cirrhosis. Dig Dis Sci (2009) 0.75
Management of biliary strictures following liver transplantation. Dig Dis Sci (2008) 0.75
Diagnostic markers for hepatitis virus infection. Expert Opin Med Diagn (2008) 0.75
Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol (2017) 0.75
Hypoglycemic coma in a pregnant woman in association with hepatitis B virus carrier state and hepatocellular carcinoma. J Clin Gastroenterol (2004) 0.75
Positive CAGE screen correlates with cirrhosis in veterans with chronic hepatitis C. Dig Dis Sci (2007) 0.75